Device Trial Radar · NCT05788757
Optetrak Knee System Post Market Clinical Follow-Up
Last checked: Nov 19, 2026Latest source record: Jun 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
4,588
Planned (sponsor's estimate)
Start
Jun 1, 2011
Primary completion
Dec 31, 2033
Study completion Jun 1, 2034
Sponsor
- Lead sponsor
- ExactechNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 29, 2023
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Post-Market Domestic (US) and International Data Collection to Assess the Optetrak Knee System
Conditions
- Knee Arthroplasty, Total
Interventions
Optetrak Total Knee SystemDevice
Total Knee Arthroplasty using Exactech's Optetrak branded components.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Knee Society ScoreTime frame: Preoperative
- Knee Society ScoreTime frame: 6 month postoperative
- Knee Society ScoreTime frame: annually through study completion, maximum of 10-years
6 more outcomes with a free account
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Fallon Clinic
Worcester, Massachusetts
Nevada Orthopaedic and Spine Center
Las Vegas, Nevada
Medical University South Carolina
Charleston, South Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.